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IDENTIFICATION AND CHARACTERISATION OF MICRORNAS INVOLVED IN
CHONDROCYTE DIFFERENTIATION AND OSTEOARTHRITIS
T.E. Swingler1, K.L. Culley1, F. Nicolas1, S.M. Soond1, M. Abu-Elmagd1,
R.P. Boot-Handford2, D.A. Young3, A. Chantry1, A. Munsterberg1,
M. Hajihosseini1, T. Dalmay1, I.M. Clark1
1Univ. of East Anglia, Norwich, United Kingdom; 2Univ. of Manchester,
Manchester, United Kingdom; 3Newcastle Univ., Newcastle, United Kingdom
Purpose: The majority of skeletal bones develop through the process of en-
dochondral ossiﬁcation. Mesenchymal cells aggregate where future bones
will develop. These early chondrocyte cells begin a series of differentiation
events, including proliferation, hypertrophy, terminal differentiation, min-
eralization and programmed cell death. Many of the signalling pathways
and transcription factors which control this developmental programme
have been established. MicroRNAs (miRNAs) have emerged as a new class
of gene expression regulators. MiRNAs are 20-24 nucleotide non-coding
RNA molecules that post-transcriptionally regulate gene expression. Little is
known about miRNA expression or function in chondrocyte differentiation.
In this study we aimed to proﬁle expression of miRNAs in a cell model of
chondrocyte differentiation, verify expression of key miRNAs in vivo and
investigate function.
Methods: The ATDC5 murine embryonic carcinoma cell line was induced to
differentiate through chondrogenesis in vitro. An Exiqon miRNA microarray
was used to proﬁle the expression of all known murine miRNAs across
this cell model. Expression of regulated miRNAs was veriﬁed in the mouse
and chick embryo by in situ hybridisation (ISH) using locked nucleic acid
probes. To investigate the role of key miRNAs we performed database
searches to identify potential targets. 3’ UTRs of potential targets were
subcloned downstream of a luciferase gene for experimental validation in
either SW1353 or C3H10T1/2 cell lines. Expression of key miRNAs was also
measured in normal and osteoarthritic cartilage using quantitative RT-PCR.
Results: ATDC5 cell differentiation was veriﬁed via GAG staining and
measurement of key markers by qRT-PCR (e.g. type II and X collagens).
In the expression screen of 609 murine miRNAs, we identiﬁed 23 miRNAs
which were signiﬁcantly regulated. Of these, we have pursued miR140
and miR455 for further analyses. The expression of both these microR-
NAs increased across the time course of differentiation just ahead of
hypertrophic markers. We and others have previously shown miR140 to be
cartilage-speciﬁc. Mir455 is located in an intron of a cartilage collagen gene,
Col27a1. ISH shows miR455 is expressed in the developing chick and mouse
embryo in the developing skeleton. We (Dalmay) have recently shown that
miR140 targets Smad3 to decrease TGFβ signalling. Like miR140, miR455
diminishes Smad-dependent signalling to a (CAGA)12-luciferase construct.
Furthermore, the expression of both miR140 and miR455 is induced by
TGFβ1, TGFβ3 and activinA. Preliminary experiments suggest that mir455
targets Smad2 and the type II activin receptor, acvr2b. Both miR140 and
miR455 are also increased in expression in human osteoarthritic cartilage
compared to normal.
Conclusions: A number of microRNAs are strongly regulated during chon-
drocyte differentiation. At least miR140 and miR455 have the potential
to modulate Smad signalling in the growth plate and to function as
regulators of chondrocyte proliferation and hypertrophy during endochon-
dral ossiﬁcation. The increase in expression of miR140 and miR455 in
human osteoarthritic cartilage may (i) diminish Smad signalling and/or (ii)
reﬂect or regulate the recapitulation of the chondrocyte developmental
programme, contributing to pathogenesis.
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CARTILAGE-SPECIFIC MICRORNA-140 REGULATES TISSUE HOMEOSTASIS
AND PROTECTS AGAINST OSTEOARTHRITIS-LIKE PATHOLOGY
S. Miyaki1, T. Sato2, A. Inoue2, S. Otsuki1, Y. Ito2, S. Yokoyama2, Y. Kato3,
S. Yamashita2, T. Nakasa2, M.K. Lotz1, H. Kudo-Ueno2, H. Asahara1
1The Scripps Res. Inst., La jolla, CA; 2Natl. Ctr. for Child Hlth.and Dev., Tokyo,
Japan; 3Natl. Inst. of Advanced Sci. and Technology, Tsukuba, Japan
Purpose: MicroRNAs (miRNAs) are a class of non-coding RNAs that nega-
tively regulates gene expression by promoting mRNA degradation and/or
repressing translation through partial sequence-speciﬁc interactions with
the 3’ untranslated regions (UTRs) of speciﬁc mRNA targets. MiRNAs show
tissue speciﬁc expression patterns, suggesting that these miRNAs play a
crucial role in tissue speciﬁc physiological processes and also in human
diseases. We previously observed that miR-140 has an expression pattern
suggestive of a role in chondrocyte differentiation and found that reduced
miR-140 expression in human OA cartilage. Reduced miR-140 expression in
human OA cartilage prompted us to determine whether miR-140 functions
in cartilage homeostasis. The objective of this study was to deﬁne the in
vivo function of the chondrocyte speciﬁc miR-140 in cartilage homoestasis.
Methods: To examine the functions of miR-140, we created a mouse
deleted for miR-140 and miR-140 TG mouse, and collected knee joints and
chondrocytes from these mice. To examine OA-like pathological changes in
articular cartilage, we utilized three different animal models of osteoarthri-
tis: an aging model, a surgical model, and an antigen-induced arthritis
(AIA) model. We used a validated histological scoring system based on
Safranin O staining and evaluated expression of cartilage related genes by
immunohistochemistry. In vitro proteoglycan catabolism was analyzed in
cultured femoral head cartilage explants from wild-type, miR-140 TG and
miR-140-/- mice. To identify target genes of miR-140, DNA microarray
analysis and bioinformatic search were performed. Double-strand (ds) RNA
oligos representing mature sequences that mimic endogenous miR-140
were transfected into chondrocytes. Finally, target gene 3’ UTR which
includes a putative miR-140 binding site was cloned downstream of a
luciferase expression vector and the luciferase activity was measured.
Results: OA-like pathology in miR-140-/- mice: Postnatally, miR-140-/-
mice manifested a mild skeletal phenotype, with short stature and cranio-
facial deformities characterized by a short snout and domed skull. First, we
tested whether loss of miR-140 affected age-related onset of OA changes,
and observed that miR-140-/- mice developed an age-related OA-like
pathology. Consistent with observations in the aging OA model, the surgical
model also demonstrated that miR-140-/- mice exhibit accelerated OA-like
changes in knee joints compared with the wild type. Next, to examine
whether miR-140 level in articular chondrocytes affects cartilage sensitivity
to experimental challenge, we assessed AIA model. Although miR-140-/-
mice showed reduced Safranin O staining, importantly, miR-140 TG mice
were resistant to proteoglycan and type II collagen loss compared with
wild-type mice.
Target gene of miR-140: Identiﬁcation of miR-140 target genes could
provide new insight into miR-140 function and OA pathogenesis. DNA
microarray analysis was performed on RNA samples, and many genes
were up-regulated in miR-140-/- chondrocytes compared to wild-type
chondrocytes. Adamts-5 emerged as one of strong candidate for miR-140
regulation, and its expression was signiﬁcantly increased in miR-140-/-
mice chondrocytes, and this correlated with increased Adamts-5 pro-
tein expression in articular cartilage as seen by immunohistochemistry.
Cartilage explants from miR-140-/- mice showed signiﬁcantly increased
proteoglycan release compared to wild-type cartilage. Treatment of chon-
drocytes with ds-miR140 reduced Adamts-5 expression. Luciferase data
indicate that miR-140 directly regulates Adamts-5 expression.
Conclusions: OA-like changes in miR-140-deﬁcient mice can be attributed,
in part, to elevated Adamts-5 expression, regulated directly by miR-140.
We show that miR-140 regulates cartilage development and homeostasis,
and its loss contributes to the development of age-related OA-like changes.
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THE MICRORNAS AS BIOMARKERS SPECIFIC OF KNEE OSTEOARTHRITIS
Y.-M. Pers1,2, S. Fabre1, F. Djouad2, I. Duroux-Richard2, F. Apparailly2,
D. Noel2, C. Jorgensen1,2
1Unité Thérapeutique Clinique des Maladies Ostéoarticulaires, Montpellier,
France; 2INSERM U844, Montpellier, France
Purpose: We are lacking biomarkers predictive of diagnosis and disease
progression in OA. MicroRNAs are small RNAs of 21-23 nucleotides able to
inhibit gene expression. The objective of this work is to identify the original
miRNAs as biomarkers in two different chronic bone and joint diseases,
osteoarthritis (OA) and RA.
Methods: Serum samples and fresh blood were obtained from 21 patients
with severe knee osteoarthritis (score of Kellgren/Lawrence at least 3/4),
8 RA patients and 10 healthy donors as controls. We performed RNA
extraction and qRT-PCR by TaqMan microRNA kit. We analyzed the sys-
temic expression of miRNAs in the 3 groups of patients using microRNA
microarrays (Miltenyi). We identiﬁed the predictive targets of miRNAs
using the DIANA-microT software.
Results: OA patients had a mean age of 71 years, had a mean radiological
score of Kellgren/Lawrence of 3.8 and their pain has evolved over 7 years.
We identiﬁed 37 miRNAs in RA and 18 miRNAs in severe knee osteoarthritis
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whose blood expression was altered compared to healthy subjects. In OA, 9
miRNA were up-regulated (including miR-228, miR-574-3p, miR-597) and
9 miRNAs were down-regulated (including miR-150, miR-222, miR-363
and miR-423). None of miRNAs in OA is common with those we found
in RA. Potential targets of miRNAs, speciﬁcally expressed in severe knee
osteoarthritis, appears to be largely involved in the Wnt signaling pathway.
In contrast, the miRNAs expressed differently in the blood of our RA
patients seem to target the elements of the signaling pathway MAP kinase.
Conclusions: Our results suggest that miRNAs may constitute new
biomarkers potential diagnostic interest. In addition, miRNAs could be
involved in the pathogenesis of OA. Further work is ongoing in order to
assess the pathophysiological and the functional role of these miRNAs in
OA.
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STATIN USE IS ASSOCIATEDWITH REDUCED INCIDENCE AND
PROGRESSION OF KNEE OSTEOARTHRITIS
S. Clockaerts1,2 , B. Stricker2, Y.M. Bastiaansen-Jenniskens2, F. Van
Glabbeek1, J.B. Van Meurs2, J.A. Verhaar2, A. Hofman2, G.V. Van Osch2,
S.M. Bierma-Zeinstra2
1Univ. of Antwerp, Edegem, Antwerp, Belgium; 2Erasmus MC, Univ. Med. Ctr.,
Rotterdam, Netherlands
Purpose: Besides biomechanical and genetic alterations, the pathogenesis
of osteoarthritis (OA) may involve inﬂammation, vascular alterations and
dysregulation of lipid metabolism. Statins are drugs capable of modulating
many of these different mechanisms and therefore may have the potential
to act as disease modifying drugs for osteoarthritis. In this study we
hypothesized that statins decrease incidence and progression of knee and
hip OA. To test this hypothesis, we used a large population cohort study.
Methods: 2974 subjects of the Rotterdam Study (a population-based cohort
study), aged 55 years and older were included in this study. X-rays of
the knee and the hip were obtained at baseline and follow up (mean
follow up 6.3 years), and were scored with the Kellgren & Lawrence score
(0=absent OA, 1=doubtful OA, 2=mild OA, 3=moderate OA, 4=severe OA, 5=
prosthesis). Incidence of OA was deﬁned as a Kellgren & Lawrence score
of 0 or 1 and a score of 2 or more at follow up. Progression of OA was
speciﬁed as a Kellgren & Lawrence score of 1, 2 or 3 and increase of 1 or
more. Information on statin use was obtained from detailed computerized
pharmacy data. Use of statins was deﬁned as the daily use of 50% or more
of recommended dose and this for a period of 100 days or more. Data
on potential confounding variables such as age, gender, body mass index,
diabetes mellitus, arterial hypertension, peripheral artery disease, bone
mineral density and total cholesterol level were collected. A multivariate
logistic regression model adjusting for confounding variables was ﬁtted to
calculate odds ratios with conﬁdence intervals. Correlations between right
and left joints were accounted for with generalized estimating equations.
Results: Osteoarthritis (Kellgren & Lawrence score 2 or more) was present
in 546 knees and 323 hips at baseline and in 696 knees and 521 hips at
follow up in 1277 men and 1697 women. Overall, 13.2% of subjects were
deﬁned as statin users. The adjusted odds ratios for incidence of knee OA
in users of statins was 0.40 (95% CI 0.20 - 0.80, p=0.01) and for progression
of knee OA 0.47 (95% CI 0.25 - 0.87, p=0.02). The use of statins was neither
associated with incidence of hip OA (adjusted odds ratio 0.85, 95% CI 0.54 -
1.34, p=0.48), nor with progression of hip OA (adjusted odds ratio 1.13, 95%
CI 0.71 - 1.81, p=0.61).
Conclusions: Statin use is associated with a reduction in incidence and
progression of knee osteoarthritis. Randomized clinical trials in a popula-
tion at risk are needed to examine whether statins could be useful as a
treatment for knee OA.
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EIGHTY-SEVEN PERCENT OF 66 ADULT PATIENTS WITH ADVANCED
OSTEOARTHRITIS OF THE KNEE SUBJECTED TO TREATMENTWITH
INTRA-ARTICULAR INJECTIONS OF HUMAN GROWTH HORMONE AVOID
TOTAL KNEE ARTHROPLASTY
A.R. Dunn
Mt. Sinai Med. Ctr., Miami Beach, FL
Purpose: Intra-articular injections of growth hormone produce Pre-natal
Developmental Healing (PDH). This unique action of growth hormone,
proven in mature rabbits, does not involve bleeding, clot formation or the
in-pouring of inﬂammatory cells. This healing is scar-free and produces
no ﬁbroartilage. The cascade of PDH ﬁrst involves the rejuvenation of
mature subchondral arteries to form fetal fenestrated capillaries which
produce autologous stem cells. These are the same vessels which produce
the fetal cartilage skeleton in utero. These stem cells are signaled to form
chondrocytes and by the completion of the PDH cascade real articular
cartilage with vertical parallel columns of chondrocytes form with arcades
at the surface and 100 per cent bonding to host bone. This method is the
ﬁrst to regrow real articular cartilage.
Method: Sixty-six adults with advanced osteoarthritis of the knee were
treated with intra-articular injections of Human Growth Hormone (HGH).
One-third required arthroscopic debridement and abrasion of eburnated
bone on the condyles.
Each knee received from eight to ﬁfteen weekly injections of Human
Growth Hormone (HGH). Dosage varied according to the size of the knee.
All patients were required to be non weight bearing on the treated side for
the duration of the treatment. Patients were required to perform simple
exercises at home. Less than one-fourth required physiotherapy.
There were no complications or side effects from the surgery or the
injections of human growth hormone (HGH)
Results: Eighty-seven percent of the patients had good to excellent results.
Several before and after X-rays of the HGH treated knees will be presented.
These X-rays demonstrate an increase of the joint spaces from 2 to 5 mm.
Evaluation with the IKDC format will be presented in graph form. There
were no infections, complications, side effects, deep vein thrombosis, pul-
monary embolism or deaths. The patients who did not respond were no
worse. Six per cent went on to have total knee arthroplasty (TKA). the
remainder were undecided about having TKA.
Conclusions: A safe, cost-effective alternative to TKA is presented. There
were no complications such as those which arise from TKA. The cost of
treatment with HGH even including arthroscopic surgery is one-fourth that
of TKA. And the additional costs of treating infected TKA are completely
avoided. Many orthopedic surgeons are concerned that their livelihood
will be adversely impacted by loss of TKA surgery; however, they should
consider that there is no need for hospital rounds, or need to treat infec-
tions and other serious complications. Insurance companies and Medicare
or other government insurance programs can save billions of dollars every
year by avoiding costly TKA surgeries at $35,000.00 per TKA.
The author recommends that this HGH treatment, which he named IAGH,
be the ﬁrst choice for treating advanced osteoarthritis of the knee.
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EFFECT OF ROSEMARY EXTRACT AND RELATED FLAVONOID CARNOSOL
ON CHONDRO-PROTECTION AND ON THE BONE-CARTILAGE CROSSTALK
M.-N. Horcajada1, C. Sanchez2, F. Scalfo1, L. Ameye1, Y. Henrotin2,
E. Offord1
1Nestle, Lausanne, Switzerland; 2Univ. of Liège, Liège, Belgium
Purpose: The aim of this work was to evaluate the effect of Rosemary
extract (P31, Robertet, France) and one of its associated ﬂavonoids, carnosol
(Sigma, Buchs, Switzerland) on metabolic functions of chondrocytes and
osteoblasts, as well as on the bone-cartilage crosstalk.
Methods: Content of carnosol in rosemary extract P31 was around 7%.
Rosemary extract and carnosol eﬃcacy were assessed at various concentra-
tions in the different experiments: 3-25μg/ml and 6nM-30μM, respectively.
Normal and Osteoarthritic (OA) human chondrocytes were cultured in al-
ginate beads for 12 days in presence or absence of both compunds.
Production of aggrecan (AGG), stromelysin (MMP-3), interleukin (IL)-6 and
nitric oxide were analyzed. Isolated human osteoblasts from sclerotic (SC)
or non sclerotic (NSC) subchondral bone were cultured for 3 days in
presence or absence of both compounds and alkaline phosphatise (AP)
activity, interleukin-6 and prostaglandin PGE2 levels were determined.
Finally, subchondral osteoblasts coming from NSC or SC areas were incu-
bated with rosemary extract or carnosol for 72h before coculture with OA
chondrocytes in alginate beads. After 4 days of co-culture, we analyzed
AGG content of the alginate beads, and chondrocytes gene expression of
AGG, type II collagen, MMP-3, MMP-13 and osteopontin (OPN).
Results: In both OA and normal chondrocytes, AGG production was signif-
icantly increased with 9 μM carnosol. MMP-3 and nitric oxide production
was signiﬁcantly decreased by both compounds, in a dose-dependent
manner, while only carnosol signiﬁcantly decreased the cytokine IL-6
secretion. Regarding osteoblast cultures, AP activity was not affected in the
